Details for: DOCK8

Gene ID: 81704

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: DOCK8

Ensembl ID: ENSG00000107099

Description: dedicator of cytokinesis 8

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • choroid plexus epithelial cell CL0000706
    CSI 55.02
    rCSI 90.11%
    PRS 30.06
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 52.32
    rCSI 40.31%
    PRS 36.53
  • central nervous system macrophage CL0000878
    CSI 24.72
    rCSI 81.92%
    PRS 39.94
  • renal interstitial pericyte CL1001318
    CSI 24.61
    rCSI 67.83%
    PRS 35.41
  • myeloid dendritic cell CL0000782
    CSI 23.32
    rCSI 33.78%
    PRS 53.53
  • microglial cell CL0000129
    CSI 20.97
    rCSI 84.42%
    PRS 51.02
  • intermediate monocyte CL0002393
    CSI 18.22
    rCSI 27.49%
    PRS 39.53
  • mature microglial cell CL0002629
    CSI 18
    rCSI 74.81%
    PRS 40.35
  • BEST4+ enteroycte CL4030026
    CSI 16.71
    rCSI 20.78%
    PRS 40.47
  • retinal cone cell CL0000573
    CSI 15.39
    rCSI 24.77%
    PRS 30.01
  • Hofbauer cell CL3000001
    CSI 13.06
    rCSI 24.66%
    PRS 47.29
  • naive B cell CL0000788
    CSI 11.65
    rCSI 9.99%
    PRS 47.84
  • common lymphoid progenitor CL0000051
    CSI 10.83
    rCSI 14.47%
    PRS 60.49
  • early lymphoid progenitor CL0000936
    CSI 10.63
    rCSI 9.34%
    PRS 42.78
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 10.02
    rCSI 8.03%
    PRS 59.12
  • renal alpha-intercalated cell CL0005011
    CSI 9.67
    rCSI 12.93%
    PRS 45.89
  • epithelial cell of proximal tubule CL0002306
    CSI 9.1
    rCSI 22.23%
    PRS 35.1
  • thymocyte CL0000893
    CSI 8.11
    rCSI 28.83%
    PRS 75.71
  • naive T cell CL0000898
    CSI 8.07
    rCSI 5.62%
    PRS 50.12
  • CD4-positive helper T cell CL0000492
    CSI 8.06
    rCSI 6.1%
    PRS 49.51
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 7.22
    rCSI 18.82%
    PRS 37.13
  • kidney connecting tubule epithelial cell CL1000768
    CSI 6.95
    rCSI 17.62%
    PRS 29.96
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 6.64
    rCSI 40.2%
    PRS 63.77
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 6.63
    rCSI 4.76%
    PRS 49.95
  • retinal pigment epithelial cell CL0002586
    CSI 6.23
    rCSI 12.37%
    PRS 37.95
  • plasmablast CL0000980
    CSI 6.02
    rCSI 4.73%
    PRS 44.03
  • myeloid cell CL0000763
    CSI 5.93
    rCSI 24.42%
    PRS 59.81
  • lung interstitial macrophage CL4033043
    CSI 5.91
    rCSI 13.27%
    PRS 58.94
  • goblet cell CL0000160
    CSI 5.5
    rCSI 5.2%
    PRS 39.13
  • double negative thymocyte CL0002489
    CSI 5.41
    rCSI 3.76%
    PRS 45.65
  • mucosal invariant T cell CL0000940
    CSI 5.39
    rCSI 4.36%
    PRS 49.3
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 5.24
    rCSI 5.14%
    PRS 52.81
  • precursor B cell CL0000817
    CSI 5.22
    rCSI 4.57%
    PRS 47.41
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 5.01
    rCSI 3.52%
    PRS 62.25
  • small intestine goblet cell CL1000495
    CSI 5
    rCSI 10.94%
    PRS 47.75
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 4.95
    rCSI 11.28%
    PRS 37.12
  • alpha-beta T cell CL0000789
    CSI 4.69
    rCSI 5.5%
    PRS 52.34
  • promyelocyte CL0000836
    CSI 4.63
    rCSI 6.68%
    PRS 48.02
  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 4.61
    rCSI 3.45%
    PRS 71.6
  • diffuse bipolar 3b cell CL4033030
    CSI 4.46
    rCSI 29.58%
    PRS 37.34
  • hematopoietic stem cell CL0000037
    CSI 4.41
    rCSI 2.93%
    PRS 42.16
  • melanocyte CL0000148
    CSI 4.36
    rCSI 3.23%
    PRS 32.64
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 4.35
    rCSI 7.68%
    PRS 23.69
  • B cell CL0000236
    CSI 4.31
    rCSI 5.77%
    PRS 70.64
  • mature NK T cell CL0000814
    CSI 4.23
    rCSI 5.41%
    PRS 73.3
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 4.21
    rCSI 3.21%
    PRS 48.33
  • immature B cell CL0000816
    CSI 4.16
    rCSI 3.09%
    PRS 50.63
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 4.11
    rCSI 2.74%
    PRS 64.74
  • plasmacytoid dendritic cell, human CL0001058
    CSI 4.11
    rCSI 2.87%
    PRS 39.8
  • macrophage CL0000235
    CSI 4.06
    rCSI 7.39%
    PRS 69.92
  • IgG plasma cell CL0000985
    CSI 3.98
    rCSI 4.77%
    PRS 56.78
  • helper T cell CL0000912
    CSI 3.94
    rCSI 5.57%
    PRS 47.61
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 3.89
    rCSI 3.6%
    PRS 58.24
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 3.83
    rCSI 19.21%
    PRS 48.29
  • group 3 innate lymphoid cell CL0001071
    CSI 3.75
    rCSI 2.81%
    PRS 40.93
  • lung macrophage CL1001603
    CSI 3.73
    rCSI 8.34%
    PRS 43.99
  • non-classical monocyte CL0000875
    CSI 3.63
    rCSI 5.82%
    PRS 67.97
  • renal beta-intercalated cell CL0002201
    CSI 3.62
    rCSI 8.62%
    PRS 40.77
  • basophil CL0000767
    CSI 3.61
    rCSI 7.63%
    PRS 59.57
  • memory B cell CL0000787
    CSI 3.56
    rCSI 3.51%
    PRS 74.78
  • inflammatory macrophage CL0000863
    CSI 3.51
    rCSI 6%
    PRS 64.3
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 3.5
    rCSI 3.44%
    PRS 67.25
  • tissue-resident macrophage CL0000864
    CSI 3.42
    rCSI 15.99%
    PRS 58.58
  • pro-B cell CL0000826
    CSI 3.41
    rCSI 2.82%
    PRS 38.85
  • kidney distal convoluted tubule epithelial cell CL1000849
    CSI 3.39
    rCSI 35.91%
    PRS 40.63
  • granulocyte CL0000094
    CSI 3.28
    rCSI 5.01%
    PRS 46.71
  • hematopoietic precursor cell CL0008001
    CSI 3.21
    rCSI 3.31%
    PRS 55.14
  • adipocyte CL0000136
    CSI 3.11
    rCSI 3.99%
    PRS 34.8
  • mature T cell CL0002419
    CSI 3.09
    rCSI 2.4%
    PRS 53.53
  • conventional dendritic cell CL0000990
    CSI 3.07
    rCSI 2.57%
    PRS 61.72
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 3.04
    rCSI 4.75%
    PRS 65.18
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 3.03
    rCSI 2.04%
    PRS 47.14
  • CD14-positive monocyte CL0001054
    CSI 3.03
    rCSI 3.78%
    PRS 49.13
  • elicited macrophage CL0000861
    CSI 3.02
    rCSI 2.77%
    PRS 44.68
  • intestine goblet cell CL0019031
    CSI 2.99
    rCSI 2.65%
    PRS 37.43
  • class switched memory B cell CL0000972
    CSI 2.97
    rCSI 2.22%
    PRS 56.28
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 2.9
    rCSI 3.52%
    PRS 36.67
  • CD8-positive, alpha-beta memory T cell CL0000909
    CSI 2.88
    rCSI 3.01%
    PRS 69.77
  • activated type II NK T cell CL0000931
    CSI 2.86
    rCSI 3.21%
    PRS 53.84
  • T follicular helper cell CL0002038
    CSI 2.81
    rCSI 2.1%
    PRS 52.27
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 2.8
    rCSI 3.97%
    PRS 35.54
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.8
    rCSI 2.85%
    PRS 50.23
  • conjunctival epithelial cell CL1000432
    CSI 2.8
    rCSI 4.27%
    PRS 38.42
  • mononuclear phagocyte CL0000113
    CSI 2.77
    rCSI 6.11%
    PRS 41.86
  • transitional stage B cell CL0000818
    CSI 2.7
    rCSI 8.84%
    PRS 71.15
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 2.69
    rCSI 2.43%
    PRS 35
  • cerebral cortex endothelial cell CL1001602
    CSI 2.69
    rCSI 4.65%
    PRS 29.94
  • hepatic stellate cell CL0000632
    CSI 2.69
    rCSI 10.06%
    PRS 32.37
  • fraction A pre-pro B cell CL0002045
    CSI 2.64
    rCSI 3.03%
    PRS 61.05
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 2.61
    rCSI 2.38%
    PRS 52.58
  • small pre-B-II cell CL0000954
    CSI 2.48
    rCSI 2.38%
    PRS 62.12
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 2.47
    rCSI 4.23%
    PRS 59.05
  • alternatively activated macrophage CL0000890
    CSI 2.47
    rCSI 3.1%
    PRS 51.2
  • ependymal cell CL0000065
    CSI 2.39
    rCSI 4.85%
    PRS 23.04
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 2.39
    rCSI 2.85%
    PRS 57.66
  • placental villous trophoblast CL2000060
    CSI 2.37
    rCSI 3.67%
    PRS 36.22
  • Kupffer cell CL0000091
    CSI 2.32
    rCSI 5.31%
    PRS 37.51
  • blood vessel endothelial cell CL0000071
    CSI 2.32
    rCSI 4.81%
    PRS 36.6
  • granulocyte monocyte progenitor cell CL0000557
    CSI 2.3
    rCSI 1.99%
    PRS 41.78
  • chondrocyte CL0000138
    CSI 2.29
    rCSI 3.64%
    PRS 32.26
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 0.2
    rCSI 0.8%
    PRS 57.5%
  • pre-conventional dendritic cell CL0002010
    CSI 0.3
    rCSI 4.1%
    PRS 72.4%
  • cytotoxic T cell CL0000910
    CSI 0.4
    rCSI 2.0%
    PRS 50.3%
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 0.4
    rCSI 2.1%
    PRS 62.1%
  • megakaryocyte progenitor cell CL0000553
    CSI 0.4
    rCSI 7.3%
    PRS 73.8%
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 0.4
    rCSI 4.8%
    PRS 72.1%
  • IgM plasma cell CL0000986
    CSI 0.5
    rCSI 2.4%
    PRS 81.8%
  • eosinophil CL0000771
    CSI 0.5
    rCSI 3.6%
    PRS 70.0%
  • myelocyte CL0002193
    CSI 0.6
    rCSI 3.6%
    PRS 73.1%
  • hepatic pit cell CL2000054
    CSI 0.6
    rCSI 7.7%
    PRS 79.5%
  • antibody secreting cell CL0000946
    CSI 0.8
    rCSI 3.4%
    PRS 82.4%
  • mature alpha-beta T cell CL0000791
    CSI 0.8
    rCSI 2.8%
    PRS 56.6%
  • myeloid dendritic cell, human CL0001057
    CSI 0.9
    rCSI 4.8%
    PRS 71.8%
  • stromal cell CL0000499
    CSI 0.9
    rCSI 2.5%
    PRS 40.1%
  • direct pathway medium spiny neuron CL4023026
    CSI 0.9
    rCSI 21.8%
    PRS 24.0%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 1.0
    rCSI 2.3%
    PRS 55.0%
  • large pre-B-II cell CL0000957
    CSI 1.0
    rCSI 2.8%
    PRS 53.1%
  • erythroid progenitor cell CL0000038
    CSI 1.0
    rCSI 5.6%
    PRS 49.0%
  • blood vessel smooth muscle cell CL0019018
    CSI 1.0
    rCSI 8.0%
    PRS 33.9%
  • innate lymphoid cell CL0001065
    CSI 1.0
    rCSI 2.1%
    PRS 46.0%
  • parietal epithelial cell CL1000452
    CSI 1.0
    rCSI 2.8%
    PRS 32.2%
  • retinal rod cell CL0000604
    CSI 1.1
    rCSI 2.0%
    PRS 36.9%
  • lung secretory cell CL1000272
    CSI 1.1
    rCSI 2.8%
    PRS 36.2%
  • nasal mucosa goblet cell CL0002480
    CSI 1.2
    rCSI 1.4%
    PRS 48.9%
  • natural T-regulatory cell CL0000903
    CSI 1.3
    rCSI 2.4%
    PRS 72.8%
  • intraepithelial lymphocyte CL0002496
    CSI 1.3
    rCSI 3.6%
    PRS 78.5%
  • intrahepatic cholangiocyte CL0002538
    CSI 1.3
    rCSI 3.2%
    PRS 55.0%
  • T-helper 1 cell CL0000545
    CSI 1.3
    rCSI 2.4%
    PRS 65.7%
  • group 2 innate lymphoid cell CL0001069
    CSI 1.3
    rCSI 7.1%
    PRS 75.2%
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 1.3
    rCSI 3.4%
    PRS 69.8%
  • tuft cell of colon CL0009041
    CSI 1.3
    rCSI 3.1%
    PRS 57.4%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.3
    rCSI 1.6%
    PRS 44.7%
  • extravillous trophoblast CL0008036
    CSI 1.4
    rCSI 1.7%
    PRS 34.2%
  • alveolar macrophage CL0000583
    CSI 1.4
    rCSI 2.3%
    PRS 43.0%
  • enteroendocrine cell of small intestine CL0009006
    CSI 1.4
    rCSI 3.2%
    PRS 52.6%
  • erythroblast CL0000765
    CSI 1.5
    rCSI 3.8%
    PRS 51.4%
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 1.5
    rCSI 1.9%
    PRS 50.9%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 1.5
    rCSI 3.0%
    PRS 55.8%
  • microcirculation associated smooth muscle cell CL0008035
    CSI 1.5
    rCSI 4.3%
    PRS 40.7%
  • kidney collecting duct intercalated cell CL1001432
    CSI 1.5
    rCSI 10.8%
    PRS 45.5%
  • promonocyte CL0000559
    CSI 1.6
    rCSI 2.7%
    PRS 47.3%
  • common dendritic progenitor CL0001029
    CSI 1.6
    rCSI 2.0%
    PRS 47.1%
  • contractile cell CL0000183
    CSI 1.7
    rCSI 4.9%
    PRS 36.6%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 1.7
    rCSI 2.3%
    PRS 58.6%
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 1.7
    rCSI 2.3%
    PRS 66.4%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 1.7
    rCSI 5.0%
    PRS 54.3%
  • intestinal tuft cell CL0019032
    CSI 1.8
    rCSI 2.7%
    PRS 42.4%
  • pulmonary alveolar type 2 cell CL0002063
    CSI 1.8
    rCSI 2.8%
    PRS 48.3%
  • professional antigen presenting cell CL0000145
    CSI 1.8
    rCSI 6.3%
    PRS 71.7%
  • neutrophil CL0000775
    CSI 1.8
    rCSI 10.2%
    PRS 52.0%
  • exhausted T cell CL0011025
    CSI 1.9
    rCSI 31.5%
    PRS 72.9%
  • Langerhans cell CL0000453
    CSI 1.9
    rCSI 2.9%
    PRS 55.6%
  • basal cell CL0000646
    CSI 1.9
    rCSI 2.5%
    PRS 39.8%
  • memory T cell CL0000813
    CSI 1.9
    rCSI 3.7%
    PRS 67.9%
  • hepatocyte CL0000182
    CSI 1.9
    rCSI 3.4%
    PRS 36.4%
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 2.0
    rCSI 1.2%
    PRS 51.6%
  • epicardial adipocyte CL1000309
    CSI 2.0
    rCSI 6.5%
    PRS 40.7%
  • dendritic cell, human CL0001056
    CSI 2.0
    rCSI 3.1%
    PRS 44.3%
  • monocyte CL0000576
    CSI 2.0
    rCSI 3.7%
    PRS 62.3%
  • common myeloid progenitor CL0000049
    CSI 2.1
    rCSI 1.7%
    PRS 38.5%
  • podocyte CL0000653
    CSI 2.1
    rCSI 9.2%
    PRS 36.7%
  • T-helper 17 cell CL0000899
    CSI 2.1
    rCSI 1.7%
    PRS 59.4%
  • regulatory T cell CL0000815
    CSI 2.1
    rCSI 2.5%
    PRS 63.0%
  • S cone cell CL0003050
    CSI 2.1
    rCSI 9.4%
    PRS 35.5%
  • erythrocyte CL0000232
    CSI 2.2
    rCSI 5.0%
    PRS 44.0%
  • retinal blood vessel endothelial cell CL0002585
    CSI 2.2
    rCSI 3.5%
    PRS 41.2%
  • dendritic cell CL0000451
    CSI 2.2
    rCSI 2.7%
    PRS 64.9%
  • germinal center B cell CL0000844
    CSI 2.2
    rCSI 6.7%
    PRS 61.8%
  • colon macrophage CL0009038
    CSI 2.2
    rCSI 10.3%
    PRS 61.5%
  • myeloid leukocyte CL0000766
    CSI 2.3
    rCSI 2.1%
    PRS 39.1%
  • mature B cell CL0000785
    CSI 2.3
    rCSI 2.0%
    PRS 46.5%
  • retinal bipolar neuron CL0000748
    CSI 2.3
    rCSI 4.3%
    PRS 29.2%
  • chondrocyte CL0000138
    CSI 2.3
    rCSI 3.6%
    PRS 32.3%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 2.3
    rCSI 2.0%
    PRS 41.8%
  • blood vessel endothelial cell CL0000071
    CSI 2.3
    rCSI 4.8%
    PRS 36.6%
  • Kupffer cell CL0000091
    CSI 2.3
    rCSI 5.3%
    PRS 37.5%
  • placental villous trophoblast CL2000060
    CSI 2.4
    rCSI 3.7%
    PRS 36.2%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 2.4
    rCSI 2.9%
    PRS 57.7%
  • ependymal cell CL0000065
    CSI 2.4
    rCSI 4.9%
    PRS 23.0%
  • alternatively activated macrophage CL0000890
    CSI 2.5
    rCSI 3.1%
    PRS 51.2%
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 2.5
    rCSI 4.2%
    PRS 59.1%
  • small pre-B-II cell CL0000954
    CSI 2.5
    rCSI 2.4%
    PRS 62.1%
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 2.6
    rCSI 2.4%
    PRS 52.6%
  • fraction A pre-pro B cell CL0002045
    CSI 2.6
    rCSI 3.0%
    PRS 61.1%
  • hepatic stellate cell CL0000632
    CSI 2.7
    rCSI 10.1%
    PRS 32.4%
  • cerebral cortex endothelial cell CL1001602
    CSI 2.7
    rCSI 4.7%
    PRS 29.9%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 2.7
    rCSI 2.4%
    PRS 35.0%
  • transitional stage B cell CL0000818
    CSI 2.7
    rCSI 8.8%
    PRS 71.2%
  • mononuclear phagocyte CL0000113
    CSI 2.8
    rCSI 6.1%
    PRS 41.9%
  • conjunctival epithelial cell CL1000432
    CSI 2.8
    rCSI 4.3%
    PRS 38.4%
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.8
    rCSI 2.9%
    PRS 50.2%
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 2.8
    rCSI 4.0%
    PRS 35.5%
  • T follicular helper cell CL0002038
    CSI 2.8
    rCSI 2.1%
    PRS 52.3%
  • activated type II NK T cell CL0000931
    CSI 2.9
    rCSI 3.2%
    PRS 53.8%
  • CD8-positive, alpha-beta memory T cell CL0000909
    CSI 2.9
    rCSI 3.0%
    PRS 69.8%
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 2.9
    rCSI 3.5%
    PRS 36.7%
  • class switched memory B cell CL0000972
    CSI 3.0
    rCSI 2.2%
    PRS 56.3%
  • intestine goblet cell CL0019031
    CSI 3.0
    rCSI 2.7%
    PRS 37.4%
  • elicited macrophage CL0000861
    CSI 3.0
    rCSI 2.8%
    PRS 44.7%
  • CD14-positive monocyte CL0001054
    CSI 3.0
    rCSI 3.8%
    PRS 49.1%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [DOCK8](/details-gene/81704) (Dedicator of cytokinesis 8) is a protein-coding gene located on chromosome 9p24.3 that functions as a guanyl-nucleotide exchange factor (GEF). It plays a crucial role in intracellular signaling pathways by activating small GTPases, particularly those of the Rho family such as Cdc42 and Rac1. This function is integral to cytoskeletal organization, cell migration, and the formation of the immunological synapse. Expression data highlights its significance in various immune cells, including monocytes, macrophages, and dendritic cells, consistent with its established role in immune function. Mutations in [DOCK8](/details-gene/81704) are associated with a combined immunodeficiency syndrome (OMIM [243700](https://omim.org/entry/243700)), underscoring its essential role in maintaining a competent immune system. Interestingly, high significance is also observed in non-classical immune cells like [choroid plexus epithelial cell](/details-cell/CL0000706), suggesting potentially uncharacterized roles. ## Cellular Roles and Expression Landscape The **Overall** expression profile of [DOCK8](/details-gene/81704) reveals its profound importance in cells of the myeloid lineage. It shows high significance in [CD14-low, CD16-positive monocyte](/details-cell/CL0002396) (CSI: 52.32), [myeloid dendritic cell](/details-cell/CL0000782) (CSI: 23.32), and various tissue-resident macrophage populations, including [central nervous system macrophage](/details-cell/CL0000878) (CSI: 24.72) and [microglial cell](/details-cell/CL0000129) (CSI: 20.97). This pattern is consistent with its function in regulating cell migration and immune surveillance, processes fundamental to these cell types. A publication has demonstrated that [DOCK8](/details-gene/81704) is a critical Cdc42 activator for the interstitial migration of dendritic cells during immune responses [Link](https://doi.org/10.1182/blood-2012-01-407098). Beyond the myeloid compartment, [DOCK8](/details-gene/81704) also shows relevance in lymphoid development, as evidenced by its expression in [common lymphoid progenitor](/details-cell/CL0000051) (CSI: 10.83), [early lymphoid progenitor](/details-cell/CL0000936) (CSI: 10.63), [naive B cell](/details-cell/CL0000788) (CSI: 11.65), and [CD4-positive, alpha-beta thymocyte](/details-cell/CL0000810) (CSI: 10.02). This suggests a role in the development and function of both innate and adaptive immunity. Notably, the cell type with the highest significance is the [choroid plexus epithelial cell](/details-cell/CL0000706) (CSI: 55.02). This is an unexpected finding given the gene's well-established immunological role, and it may point to a specialized function in regulating the cytoskeletal architecture and barrier integrity of the blood-cerebrospinal fluid barrier. ## Pathways and Molecular Function Functionally, [DOCK8](/details-gene/81704) is annotated as a GEF ([GO:0005085](https://www.ebi.ac.uk/QuickGO/term/GO:0005085)) that positively regulates the activity of small GTPases ([GO:0043547](https://www.ebi.ac.uk/QuickGO/term/GO:0043547)). This is central to its involvement in biological processes such as the [regulation of Rho protein signal transduction](/details-go/GO:0035023) and [small GTPase-mediated signal transduction](/details-go/GO:0007264). Its activity directly feeds into pathways controlling cell motility, including [positive regulation of T cell migration](/details-go/GO:2000406) and [dendritic cell migration](/details-go/GO:0036336). Consistent with a role in cell migration and intercellular communication, its protein product is localized to dynamic membrane structures like the [cell leading edge](/details-go/GO:0031252) and [lamellipodium membrane](/details-go/GO:0031258). Reactome pathway analysis further solidifies its role as a key regulator of the [Rho GTPase cycle](/details-pathway/R-HSA-9012999), specifically implicating it in the [Cdc42 GTPase cycle](/details-pathway/R-HSA-9013148) and the [Rac1 GTPase cycle](/details-pathway/R-HSA-9013149). These signaling cascades are fundamental to numerous cellular activities, from immune synapse formation ([GO:0001771](https://www.ebi.ac.uk/QuickGO/term/GO:0001771)) to broader processes like [Hemostasis](/details-pathway/R-HSA-109582). ## Research Directions The available data highlights [DOCK8](/details-gene/81704) as an essential regulator of immune cell function, but also opens new avenues for investigation, particularly regarding its role outside of classical immune cells. ### Proposed Hypotheses 1. The exceptionally high CSI score in [choroid plexus epithelial cell](/details-cell/CL0000706) suggests that [DOCK8](/details-gene/81704) is a key regulator of blood-cerebrospinal fluid barrier dynamics. It may control the complex cytoskeletal arrangements required for maintaining barrier integrity and regulating immune cell trafficking into the central nervous system. 2. Given its high expression in CNS-resident immune cells ([central nervous system macrophage](/details-cell/CL0000878), [microglial cell](/details-cell/CL0000129)) and its role in T cell interaction ([GO:0001771](https://www.ebi.ac.uk/QuickGO/term/GO:0001771)), [DOCK8](/details-gene/81704) likely plays a critical, intrinsic role in microglia/macrophage activation, surveillance, and antigen presentation during neuroinflammatory conditions. ### Key Experiment To test the hypothesis regarding the role of [DOCK8](/details-gene/81704) in the choroid plexus, an *in vitro* model using human choroid plexus epithelial cells cultured on transwell inserts could be employed. [DOCK8](/details-gene/81704) expression could be silenced using siRNA or CRISPR-Cas9 knockout. The impact on barrier function would be quantified by measuring transepithelial electrical resistance (TEER) and paracellular flux of fluorescently-labeled dextrans. Changes in cytoskeletal organization and cell junction proteins (e.g., ZO-1, claudins) could be visualized and quantified using high-resolution immunofluorescence microscopy. ### Therapeutic Potential The clinical relevance of [DOCK8](/details-gene/81704) is primarily in the context of loss-of-function mutations that cause a severe combined immunodeficiency syndrome. Therefore, the therapeutic strategy is one of *activation* or *restoration*, not inhibition. The most promising avenue is gene therapy, where autologous hematopoietic stem cells are harvested from the patient, corrected *ex vivo* with a lentiviral vector carrying a functional copy of the [DOCK8](/details-gene/81704) gene, and re-infused. This approach aims to reconstitute a functional immune system and is the subject of active clinical investigation. Targeting [DOCK8](/details-gene/81704) for inhibition would be contraindicated, as it would likely mimic the disease phenotype.

Genular Protein ID: 716367964

Symbol: DOCK8_HUMAN

Name: Dedicator of cytokinesis protein 8

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 15164053

Title: DNA sequence and analysis of human chromosome 9.

PubMed ID: 15164053

DOI: 10.1038/nature02465

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 17974005

Title: The full-ORF clone resource of the German cDNA consortium.

PubMed ID: 17974005

DOI: 10.1186/1471-2164-8-399

PubMed ID: 12693554

Title: Characterization of long cDNA clones from human adult spleen. II. The complete sequences of 81 cDNA clones.

PubMed ID: 12693554

DOI: 10.1093/dnares/10.1.49

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 10729223

Title: The region on 9p associated with 46,XY sex reversal contains several transcripts expressed in the urogenital system and a novel doublesex-related domain.

PubMed ID: 10729223

DOI: 10.1006/geno.2000.6121

PubMed ID: 12432077

Title: Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.

PubMed ID: 12432077

DOI: 10.1242/jcs.00219

PubMed ID: 18060736

Title: Dedicator of cytokinesis 8 is disrupted in two patients with mental retardation and developmental disabilities.

PubMed ID: 18060736

DOI: 10.1016/j.ygeno.2007.10.011

PubMed ID: 19369195

Title: Large-scale proteomics analysis of the human kinome.

PubMed ID: 19369195

DOI: 10.1074/mcp.m800588-mcp200

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 22461490

Title: DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses.

PubMed ID: 22461490

DOI: 10.1182/blood-2012-01-407098

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 25762780

Title: HkRP3 is a microtubule-binding protein regulating lytic granule clustering and NK cell killing.

PubMed ID: 25762780

DOI: 10.4049/jimmunol.1402897

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 28028151

Title: LRCH1 interferes with DOCK8-Cdc42-induced T cell migration and ameliorates experimental autoimmune encephalomyelitis.

PubMed ID: 28028151

DOI: 10.1084/jem.20160068

PubMed ID: 19776401

Title: Combined immunodeficiency associated with DOCK8 mutations.

PubMed ID: 19776401

DOI: 10.1056/nejmoa0905506

PubMed ID: 24169519

Title: 20 ans apres: a second mutation in MAOA identified by targeted high-throughput sequencing in a family with altered behavior and cognition.

PubMed ID: 24169519

DOI: 10.1038/ejhg.2013.243

Sequence Information:

  • Length: 2099
  • Mass: 238529
  • Checksum: AF651C26E2D8E73E
  • Sequence:
  • MATLPSAERR AFALKINRYS SAEIRKQFTL PPNLGQYHRQ SISTSGFPSL QLPQFYDPVE 
    PVDFEGLLMT HLNSLDVQLA QELGDFTDDD LDVVFTPKEC RTLQPSLPEE GVELDPHVRD 
    CVQTYIREWL IVNRKNQGSP EICGFKKTGS RKDFHKTLPK QTFESETLEC SEPAAQAGPR 
    HLNVLCDVSG KGPVTACDFD LRSLQPDKRL ENLLQQVSAE DFEKQNEEAR RTNRQAELFA 
    LYPSVDEEDA VEIRPVPECP KEHLGNRILV KLLTLKFEIE IEPLFASIAL YDVKERKKIS 
    ENFHCDLNSD QFKGFLRAHT PSVAASSQAR SAVFSVTYPS SDIYLVVKIE KVLQQGEIGD 
    CAEPYTVIKE SDGGKSKEKI EKLKLQAESF CQRLGKYRMP FAWAPISLSS FFNVSTLERE 
    VTDVDSVVGR SSVGERRTLA QSRRLSERAL SLEENGVGSN FKTSTLSVSS FFKQEGDRLS 
    DEDLFKFLAD YKRSSSLQRR VKSIPGLLRL EISTAPEIIN CCLTPEMLPV KPFPENRTRP 
    HKEILEFPTR EVYVPHTVYR NLLYVYPQRL NFVNKLASAR NITIKIQFMC GEDASNAMPV 
    IFGKSSGPEF LQEVYTAVTY HNKSPDFYEE VKIKLPAKLT VNHHLLFTFY HISCQQKQGA 
    SVETLLGYSW LPILLNERLQ TGSYCLPVAL EKLPPNYSMH SAEKVPLQNP PIKWAEGHKG 
    VFNIEVQAVS SVHTQDNHLE KFFTLCHSLE SQVTFPIRVL DQKISEMALE HELKLSIICL 
    NSSRLEPLVL FLHLVLDKLF QLSVQPMVIA GQTANFSQFA FESVVAIANS LHNSKDLSKD 
    QHGRNCLLAS YVHYVFRLPE VQRDVPKSGA PTALLDPRSY HTYGRTSAAA VSSKLLQARV 
    MSSSNPDLAG THSAADEEVK NIMSSKIADR NCSRMSYYCS GSSDAPSSPA APRPASKKHF 
    HEELALQMVV STGMVRETVF KYAWFFFELL VKSMAQHVHN MDKRDSFRRT RFSDRFMDDI 
    TTIVNVVTSE IAALLVKPQK ENEQAEKMNI SLAFFLYDLL SLMDRGFVFN LIRHYCSQLS 
    AKLSNLPTLI SMRLEFLRIL CSHEHYLNLN LFFMNADTAP TSPCPSISSQ NSSSCSSFQD 
    QKIASMFDLT SEYRQQHFLT GLLFTELAAA LDAEGEGISK VQRKAVSAIH SLLSSHDLDP 
    RCVKPEVKVK IAALYLPLVG IILDALPQLC DFTVADTRRY RTSGSDEEQE GAGAINQNVA 
    LAIAGNNFNL KTSGIVLSSL PYKQYNMLNA DTTRNLMICF LWIMKNADQS LIRKWIADLP 
    STQLNRILDL LFICVLCFEY KGKQSSDKVS TQVLQKSRDV KARLEEALLR GEGARGEMMR 
    RRAPGNDRFP GLNENLRWKK EQTHWRQANE KLDKTKAELD QEALISGNLA TEAHLIILDM 
    QENIIQASSA LDCKDSLLGG VLRVLVNSLN CDQSTTYLTH CFATLRALIA KFGDLLFEEE 
    VEQCFDLCHQ VLHHCSSSMD VTRSQACATL YLLMRFSFGA TSNFARVKMQ VTMSLASLVG 
    RAPDFNEEHL RRSLRTILAY SEEDTAMQMT PFPTQVEELL CNLNSILYDT VKMREFQEDP 
    EMLMDLMYRI AKSYQASPDL RLTWLQNMAE KHTKKKCYTE AAMCLVHAAA LVAEYLSMLE 
    DHSYLPVGSV SFQNISSNVL EESVVSEDTL SPDEDGVCAG QYFTESGLVG LLEQAAELFS 
    TGGLYETVNE VYKLVIPILE AHREFRKLTL THSKLQRAFD SIVNKDHKRM FGTYFRVGFF 
    GSKFGDLDEQ EFVYKEPAIT KLPEISHRLE AFYGQCFGAE FVEVIKDSTP VDKTKLDPNK 
    AYIQITFVEP YFDEYEMKDR VTYFEKNFNL RRFMYTTPFT LEGRPRGELH EQYRRNTVLT 
    TMHAFPYIKT RISVIQKEEF VLTPIEVAIE DMKKKTLQLA VAINQEPPDA KMLQMVLQGS 
    VGATVNQGPL EVAQVFLAEI PADPKLYRHH NKLRLCFKEF IMRCGEAVEK NKRLITADQR 
    EYQQELKKNY NKLKENLRPM IERKIPELYK PIFRVESQKR DSFHRSSFRK CETQLSQGS

Genular Protein ID: 3395048009

Symbol: E2J6M5_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Sequence Information:

  • Length: 113
  • Mass: 12839
  • Checksum: B4891CB74DE49FA2
  • Sequence:
  • MTHLNSLDVQ LAQELGDFTD DDLDVVFTPK ECRTLQPSLP EEGVELDPHV RDCVQTYIRE 
    WLIVNRKNQG SPEICGFKKT GSRKDFHKTL PKQTFESETL ECSEPAAQAG PRH

Genular Protein ID: 423102159

Symbol: E2J6M6_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 19776401

Title: Combined immunodeficiency associated with DOCK8 mutations.

PubMed ID: 19776401

DOI: 10.1056/NEJMoa0905506

Sequence Information:

  • Length: 922
  • Mass: 104006
  • Checksum: 61E6A8873887319B
  • Sequence:
  • MTHLNSLDVQ LAQELGDFTD DDLDVVFTPK ECRTLQPSLP EEGVELDPHV RDCVQTYIRE 
    WLIVNRKNQG SPEICGFKKT GSRKDFHKTL PKQTFESETL ECSEPAAQAG PRHLNVLCDV 
    SGKGPVTACD FDLRSLQPDK RLENLLQQVS AEDFEKQNEE ARRTNRQAEL FALYPSVDEE 
    DAVEIRPVPE CPKEHLGNRI LVKLLTLKFE IEIEPLFASI ALYDVKERKK ISENFHCDLN 
    SDQFKGFLRA HTPSVAASSQ ARSAVFSVTY PSSDIYLVVK IEKVLQQGEI GDCAEPYTVI 
    KESDGGKSKE KIEKLKLQAE SFCQRLGKYR MPFAWAPISL SSFFSVSTLE REVTDVDSVV 
    GRSSVGERRT LAQSRRLSER ALSLEENGVG SNFKTSTLSV SSFFKQEGDR LSDEDLFKFL 
    ADYKRSSSLQ RRVKSIPGLL RLEISTAPEI INCCLTPEML PVKPFPENRT RPHKEILEFP 
    TREVYVPHTV YRSLLYVYPQ RLNFVNKLAS ARNITIKIQF MCGEDASNAM PVIFGKSSGP 
    EFLQEVYTAV TYHNKSPDFY EEVKIKLPAK LTVNHHLLFT FYHISCQQKQ GASVETLLGY 
    SWLPILLNER LQTGSYRLPV ALEKLPPNYS MHSAEKVPLQ NPPIKWAEGH KGVFNIEVQA 
    VSSVHTQDNH LKKFFTLCHS LESQVTFPIR VLDQKISEMA LEHELKLSII CLNSSRLEPL 
    VLFLHLVLDK LFQLSVQPMV IAGQTANFSQ FAFESVVAIA NSLHNSKDLS KDQHGRNCLL 
    ASYVHYVFRL PEVQRDVPKS GAPTALLDPR SYHTYGRTSA AAVSSKLLQA RVMSSSNPDL 
    AGTHSAADEE VKNIMSSKIA DRNCSRMSYY CSGSSDAPSS PAAPRPASKK HFHKELALQM 
    VVSTGMVRET VFKYAWFFFE LL